These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 9105265)
21. Confirmation of LSD intoxication by analysis of serum and urine. McCarron MM; Walberg CB; Baselt RC J Anal Toxicol; 1990; 14(3):165-7. PubMed ID: 2374406 [TBL] [Abstract][Full Text] [Related]
22. Radioimmunoassay of lysergic acid diethylamide (LSD) in serum and urine by using antisera of different specificities. Ratcliffe WA; Fletcher SM; Moffat AC; Ratcliffe JG; Harland WA; Levitt TE Clin Chem; 1977 Feb; 23(2 PT. 1):169-74. PubMed ID: 832379 [TBL] [Abstract][Full Text] [Related]
23. False-positive LSD drug screening induced by a mucolytic medication. Lotz J; Hafner G; Röhrich J; Zörntlein S; Kern T; Prellwitz W Clin Chem; 1998 Jul; 44(7):1580-1. PubMed ID: 9665451 [No Abstract] [Full Text] [Related]
24. False-positive LSD testing in urine samples from intensive care patients. Röhrich J; Zörntlein S; Lotz J; Becker J; Kern T; Rittner C J Anal Toxicol; 1998 Sep; 22(5):393-5. PubMed ID: 9737335 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of the triage system for emergency drugs-of-abuse testing in urine. Wu AH; Wong SS; Johnson KG; Callies J; Shu DX; Dunn WE; Wong SH J Anal Toxicol; 1993; 17(4):241-5. PubMed ID: 8371556 [TBL] [Abstract][Full Text] [Related]
26. Liquid chromatography-electrospray ionization mass spectrometry for the detection of lysergide and a major metabolite, 2-oxo-3-hydroxy-LSD, in urine and blood. Sklerov JH; Magluilo J; Shannon KK; Smith ML J Anal Toxicol; 2000 Oct; 24(7):543-9. PubMed ID: 11043657 [TBL] [Abstract][Full Text] [Related]
27. In vitro metabolic fate of nine LSD-based new psychoactive substances and their analytical detectability in different urinary screening procedures. Wagmann L; Richter LHJ; Kehl T; Wack F; Bergstrand MP; Brandt SD; Stratford A; Maurer HH; Meyer MR Anal Bioanal Chem; 2019 Jul; 411(19):4751-4763. PubMed ID: 30617391 [TBL] [Abstract][Full Text] [Related]
28. LC-mS analysis of human urine specimens for 2-oxo-3-hydroxy LSD: method validation for potential interferants and stability study of 2-oxo-3-hydroxy LSD under various storage conditions. Klette KL; Horn CK; Stout PR; Anderson CJ J Anal Toxicol; 2002; 26(4):193-200. PubMed ID: 12054358 [TBL] [Abstract][Full Text] [Related]
29. Advantages of analyzing postmortem brain samples in routine forensic drug screening-Case series of three non-natural deaths tested positive for lysergic acid diethylamide (LSD). Mardal M; Johansen SS; Thomsen R; Linnet K Forensic Sci Int; 2017 Sep; 278():e14-e18. PubMed ID: 28803722 [TBL] [Abstract][Full Text] [Related]
30. Automated extraction of lysergic acid diethylamide (LSD) and N-demethyl-LSD from blood, serum, plasma, and urine samples using the Zymark RapidTrace with LC/MS/MS confirmation. de Kanel J; Vickery WE; Waldner B; Monahan RM; Diamond FX J Forensic Sci; 1998 May; 43(3):622-5. PubMed ID: 9608700 [TBL] [Abstract][Full Text] [Related]
31. Elucidation of LSD in vitro metabolism by liquid chromatography and capillary electrophoresis coupled with tandem mass spectrometry. Cai J; Henion J J Anal Toxicol; 1996; 20(1):27-37. PubMed ID: 8837948 [TBL] [Abstract][Full Text] [Related]
32. Quantitation of lysergic acid diethylamide in urine using atmospheric pressure matrix-assisted laser desorption/ionization ion trap mass spectrometry. Cui M; McCooeye MA; Fraser C; Mester Z Anal Chem; 2004 Dec; 76(23):7143-8. PubMed ID: 15571372 [TBL] [Abstract][Full Text] [Related]
33. Determination of LSD in urine with high-performance liquid chromatography--mass spectrometry. Bodin K; Svensson JO Ther Drug Monit; 2001 Aug; 23(4):389-93. PubMed ID: 11477321 [TBL] [Abstract][Full Text] [Related]
35. Indirect enzyme-linked immunosorbent assay for the quantitative estimation of lysergic acid diethylamide in urine. Kerrigan S; Brooks DE Clin Chem; 1998 May; 44(5):985-90. PubMed ID: 9590371 [TBL] [Abstract][Full Text] [Related]
36. Short-term stability of lysergic acid diethylamide (LSD), N-desmethyl-LSD, and 2-oxo-3-hydroxy-LSD in urine, assessed by liquid chromatography-tandem mass spectrometry. Skopp G; Pötsch L; Mattern R; Aderjan R Clin Chem; 2002 Sep; 48(9):1615-8. PubMed ID: 12194952 [No Abstract] [Full Text] [Related]
37. Effective GC-MS procedure for detecting iso-LSD in urine after base-catalyzed conversion to LSD. Clarkson ED; Lesser D; Paul BD Clin Chem; 1998 Feb; 44(2):287-92. PubMed ID: 9474026 [TBL] [Abstract][Full Text] [Related]
38. The effects of commonly used adulterants on the detection of spiked LSD by an enzyme immunoassay. Cassells NP; Craston DH Sci Justice; 1998; 38(2):109-17. PubMed ID: 9624820 [TBL] [Abstract][Full Text] [Related]
39. Analytical performance evaluation of EMIT II monoclonal amphetamine/methamphetamine assay: more specificity than EMIT d.a.u. monoclonal amphetamine/methamphetamine assay. Dasgupta A; Saldana S; Kinnaman G; Smith M; Johansen K Clin Chem; 1993 Jan; 39(1):104-8. PubMed ID: 8419030 [TBL] [Abstract][Full Text] [Related]
40. False-positive lysergic acid diethylamide immunoassay screen associated with fentanyl medication. Gagajewski A; Davis GK; Kloss J; Poch GK; Anderson CJ; Apple FS Clin Chem; 2002 Jan; 48(1):205-6. PubMed ID: 11751564 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]